<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365844">
  <stage>Registered</stage>
  <submitdate>21/02/2014</submitdate>
  <approvaldate>7/03/2014</approvaldate>
  <actrnumber>ACTRN12614000247673</actrnumber>
  <trial_identification>
    <studytitle>Reduction Of Chronic Post-surgical Pain with Ketamine  A Pilot Study</studytitle>
    <scientifictitle>A pilot study for a multicentre double-blind placebo controlled randomized Phase 4 study of the effect of ketamine on the development of chronic post-surgical pain in patients undergoing elective abdominal or non-cardiac thoracic surgery under general anaesthesia.</scientifictitle>
    <utrn />
    <trialacronym>ROCKet Pilot Study</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Chronic post-surgical pain</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The effect of intravenous ketamine given prior to and for up to 24 hours following surgical incision on the prevalence and severity of chronic post-surgical pain at 4-6 months postoperatively. Ketamine dosage is 0. 5mg/kg bolus, followed by 0.25 mg/kg/hr intra-operatively. then 0.1 mg/kg/hr continued for 24 hour</interventions>
    <comparator>Placebo saline</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The incidence of chronic post-surgical wound-related pain reported by the patient using a structured questionnaire incorporating the modified brief pain inventory (mBPI).</outcome>
      <timepoint>4-6 months postoperatively.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The mean severity of chronic post-surgical wound-related pain measured using a Visual Analog Scale (0-100).</outcome>
      <timepoint>4-6 months postoperatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of life estimates using the WHODAS and  Kessler K-10 Depression scale, and their relationship to pain prevalence and severity</outcome>
      <timepoint>4-6 months after surgery.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>The severity of acute postoperative pain measured using a Visual Analog Scale (0-100).</outcome>
      <timepoint>In the first 24, 48 and 72 hours postoperative</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Opioid and other analgesic consumption</outcome>
      <timepoint>The first 24, 48 and 72 hours postoperative</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>The relationship of the severity of acute postoperative pain to chronic post surgical pain prevalence and severity using a Visual Analog Scale (0-100). </outcome>
      <timepoint>4-6 months postoperative</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients undergoing elective abdominal or non-cardiac thoracic surgery under general anaesthesia involving a skin incision at least 8 cm in length and a hospital stay of at least one night postoperatively.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients unable to provide informed consent
Patients with poor English language comprehension
Patients who are pregnant
Body mass index (BMI) over 40 kg/m2 or weight over 130kg
ASA grade 4 or 5.
Uncontrolled hypertension (SBP over 180 mmHg) or heart failure
Intracranial surgery
History of haemorrhagic stroke
Previous adverse reaction to ketamine
Patients with a documented chronic pain syndrome identified using the mBPI
Patients with epilepsy or history of convulsions
Patients with a history of psychiatric problems or drug abuse or illegal activities</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>80 patients.
This study is a pilot study and is not powered to demonstrate a statistically significant difference in the primary endpoint</statisticalmethods>
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3 / Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>27/02/2014</actualstartdate>
    <anticipatedenddate>30/09/2014</anticipatedenddate>
    <actualenddate />
    <samplesize>80</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Austin Health</primarysponsorname>
    <primarysponsoraddress>145 Studley Rd
Heidelberg 3084
VIC</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Australian and New Zealand College of Anaesthetists</fundingname>
      <fundingaddress>Ulimaroa
630 St Kilda Road
Melbourne Vic 3004</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>There is a well established physiological basis for the proposition that a potent NMDA receptor antagonist such as the widely available drug ketamine given peri-operatively may reduce the development of chronic postsurgical pain in patients undergoing major surgery, and this proposition is supported by available data pooled from small placebo controlled published studies, and a large study on N2O. The potential benefits of this in reducing the burden of chronic pain in the community are substantial. 
A large multicentre randomized trial is needed in patients undergoing major surgery to determine whether chronic post-surgical pain is reduced using intravenous ketamine given peri-operatively.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Philip Peyton</name>
      <address>Dept of Anaesthesia
Austin Health
145 Studley Rd
Heidelberg 3084
VIC</address>
      <phone>+61402282398</phone>
      <fax />
      <email>phil.peyton@austin.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Philip Peyton</name>
      <address>Dept of Anaesthesia
Austin Health
145 Studley Rd
Heidelberg 3084
VIC</address>
      <phone>+61402282398</phone>
      <fax />
      <email>phil.peyton@austin.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Philip Peyton</name>
      <address>Dept of Anaesthesia
Austin Health
145 Studley Rd
Heidelberg 3084
VIC</address>
      <phone>+61402282398</phone>
      <fax />
      <email>phil.peyton@austin.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Philip Peyton</name>
      <address>Dept of Anaesthesia
Austin Health
145 Studley Rd
Heidelberg 3084
VIC</address>
      <phone>+61402282398</phone>
      <fax />
      <email>phil.peyton@austin.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>